VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ)
$24.09 0.75 (3.2134%)
Analysed VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) News Sources
Viridian Therapeutics (VRDN) Stock Still Looks Above Fair Value Today
15-07-2026
yahoo.com
Viridian Therapeutics (VRDN) Rebounds Sharply, Is The Valuation Still Too Rich?
15-07-2026
yahoo.com
Lumvoa’s Unique Profile Leads to Optimism Around Viridian Therapeutics (VRDN)
15-07-2026
yahoo.com
Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results
06-08-2026
yahoo.com
Viridian Therapeutics to See 'Minimal' Revenue Growth in H2, RBC Capital Markets Says
07-08-2026
yahoo.com
Viridian Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference
02-09-2026
yahoo.com
Viridian Therapeutics' Lumvoa Off to 'Stronger Start' Than Anticipated, RBC Says
22-09-2026
yahoo.com
Viridian Therapeutics (VRDN) Stock May Look Stretched Against Its Sales Base
17-10-2026
yahoo.com
Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026
20-10-2026
yahoo.com
How FDA Approval Will Impact Viridian Therapeutics Stock
27-10-2026
yahoo.com
What is the current price of VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ)?
The current price of VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) is $24.09.
VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) absolute price change since previous trading day?
The absolute price change of VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) since the previous trading day is $0.75.
VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) percentage price change since previous trading day?
The percentage price change of VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) since the previous trading day is 3.2134%.
What is the most recent average sentiment score for VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ)?
The most recent average sentiment score for VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) is 85 out of 100.
What is the most recent average sentiment for VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ)?
The most recent sentiment for VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) is .
SEC-8K** Filing Available For VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.